GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cynata Therapeutics Ltd (ASX:CYP) » Definitions » Cash Receipts from Fees and Commissions

Cynata Therapeutics (ASX:CYP) Cash Receipts from Fees and Commissions


View and export this data going back to 2007. Start your Free Trial

What is Cynata Therapeutics Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applies to banks.


Cynata Therapeutics (ASX:CYP) Business Description

Industry
Traded in Other Exchanges
Address
100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.